Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTungsten west Regulatory News (TUN)

Share Price Information for Tungsten west (TUN)

Share Price is delayed by 15 minutes
Get Live Data
35.25    0.25 (0.72%)
Bid:
35.00
Ask:
35.50
Spread: 0.50 (1.429%)
Market Cap: £436.69m
TUN Live PriceLast checked at - London Stock Exchange

Intraday Tungsten west Share Chart

Completion of Updated Feasibility Study

5 Aug 2025 07:00

RNS Number : 9187T
Tungsten West PLC
05 August 2025
 

05 August 2025

Tungsten West Plc

("Tungsten West", the "Company" or the "Group")

 

Completion of Updated Feasibility Study

 

Tungsten West (LON:TUN), the mining company focused on restarting production at the Hemerdon tungsten and tin mine ("Hemerdon" or the "Project") in Devon, UK, is pleased to announce the completion of its updated Feasibility Study (the "Study") for Hemerdon. An executive summary of the Feasibility Study is available on the Company's website via the following link: www.tungstenwest.com/technicalreports

 

The Company announced on 30 May 2025 a preview of the Project's economics. These remain unchanged with an IRR of 29% and an NPV7.5% of US$190 million using a Tungsten price of US$400 per Metric Tonne Unit (65% ammonium paratungstate, ("APT"), free on-board Rotterdam).

 

The Company will be hosting a live investor presentation in September, further details will follow in due course.

 

Jeff Court, CEO of Tungsten West, commented:

"The conclusion of this Feasibility Study marks a highly significant milestone for Tungsten West as we now formally commence our fundraising efforts. The Study further emphasises the strong economics of the Project, fully supported by its strong technical, environmental, community and stakeholder facets. The Study also further underlines Hemerdon's global critical minerals supply credentials.

 

"I would like to sincerely thank the entire team, including our employees and consultants for their extremely hard work to complete this Study. In addition, I would also like to thank our shareholders and financial supporters for their continued dedication and belief in our Project."

 

Ends

 

For further information, please contact:

 

Enquiries

Tungsten West

Alistair Stobie

Tel: +44 (0) 1752 278500

 

Strand Hanson

(Nominated Adviser and Financial Adviser)

James Spinney / James Dance / Abigail Wennington

Tel: +44 (0) 207 409 3494

BlytheRay

(Financial PR)

Tim Blythe / Megan Ray

Tel: +44(0) 20 7138 3204

Email: tungstenwest@blytheray.com

 

Hannam & Partners

(Broker)

Andrew Chubb / Matt Hasson / Jay Ashfield

Tel: +44 (0)20 7907 8500

 

Follow us on X @TungstenWest

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBLGDICSGDGUS
Date   Source Headline
24th Dec 20257:00 amRNSResults for the six months ended 30 September 2025
23rd Dec 20257:00 amRNSExercise of Options & TVR
23rd Dec 20257:00 amRNSExercise of Options & TVR
9th Dec 20257:00 amRNSBridge Loan, Project Financing & CLN Update
5th Dec 20257:00 amRNSBoard Change
26th Nov 20257:00 amRNSEPC Agreement for New Build Construction
7th Nov 20257:00 amRNSSuccessful Processing Trial
29th Sep 20256:20 pmRNSResults of Annual General Meeting
25th Sep 20257:00 amRNSNotice of Annual General Meeting
23rd Sep 20257:00 amRNSBoard Change
4th Sep 20253:02 pmRNS-RInvestor Presentation and Q&A
4th Sep 20257:00 amRNSFinancial Results for the Year Ended 31 March 2025
3rd Sep 20254:30 pmRNSTR-1: Notification of major holdings
28th Aug 20257:00 amRNSLoI from Export-Import Bank of the United States
5th Aug 20257:00 amRNSCompletion of Updated Feasibility Study
18th Jul 20252:50 pmRNSTR-1: Notification of major holdings
2nd Jul 20253:00 pmRNSConvertible Loan Note Update
16th Jun 20259:35 amRNS-RCorporate Presentation
10th Jun 202512:22 pmRNSTR1: Notification of major holdings
10th Jun 20257:00 amRNSDirector Dealings
5th Jun 20257:00 amRNSHemerdon designated a Strategic Project under CRMA
30th May 20257:00 amRNSDevelopment and Economic Plan for Hemerdon
28th May 20258:58 amRNSChange of Registered Address
8th May 20257:00 amRNSConvertible Loan Note Update
13th Jan 20251:20 pmRNSConvertible Loan Note Update
31st Dec 202412:41 pmRNSHalf Year Results
4th Dec 20247:00 amRNSAppointment of Chairman
3rd Dec 20244:05 pmRNSResults of Annual General Meeting
8th Nov 20243:19 pmRNSAmendment to Notice of AGM
1st Nov 20241:02 pmRNSNotice of Annual General Meeting
17th Oct 202412:40 pmRNSConvertible Loan Note Update
8th Oct 20247:00 amRNSDirectorate Change
2nd Oct 202412:00 pmRNSFinancial Results & Lifting of Trading Suspension
2nd Oct 202412:00 pmRNSRestoration - Tungsten West PLC
1st Oct 202410:08 amRNSTemporary Suspension of Trading on AIM
1st Oct 20247:30 amRNSSuspension - Tungsten West plc
15th Aug 20247:00 amRNSAppointment of Chief Executive Officer
23rd Jul 20247:00 amRNSConvertible Loan Note Update
3rd Jul 20247:00 amRNSBoard Changes
12th Jun 20247:00 amRNSMineral Processing Facility Permit Awarded
5th Jun 20247:00 amRNSBoard Change
20th May 20247:00 amRNSExercise of Options
8th May 20244:03 pmRNSExtension of EA public consultation period
28th Mar 20247:00 amRNSConvertible Loan Note Update
25th Mar 20242:00 pmRNSCommencement of EA public consultation period
7th Feb 20247:00 amRNSTR-1: Notification of major holdings
5th Feb 20247:00 amRNSReceipt of Draft Permit for MPF
22nd Dec 20237:00 amRNSHalf Year Results
18th Dec 20237:00 amRNSConvertible Loan Note Update
10th Nov 20237:00 amRNSAppointment of Chief Financial Officer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.